Home
Conditions
Lentivirus Infections

Clinical trial condition

Lentivirus Infections

Explore clinical trials studying Lentivirus Infections. Study availability and eligibility vary by location and protocol.

5,647 public trials 305 recruiting studies

Refine in advanced search Browse all conditions

Lentivirus Infections trial results

Completed

Central Nervous System Disease in HIV-infected Children on HAART

NCT00110331

Conditions: Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, Bipolar Disorder, +30 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

To Assess the Relative Bioavailability (BA) of TRIUMEQ® and Dolutegravir and Lamivudine (DTG/3TC) Pediatric Dispersible Tablet Formulations in Healthy Volunteers

NCT03441984

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: GSK Investigational Site Austin, Texas, United States

View Trial Details

Completed

Theory-based HIV Disclosure Intervention for Parents

NCT04051177

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +15 more
Locations: University of South Carolina Columbia, South Carolina, United States

View Trial Details

Completed

Hepatitis B and HIV Co-Infection in Patients in Uganda

NCT00782158

Conditions: Blood-Borne Infections, Coinfection, Communicable Diseases, +23 more
Locations: Infectious Diseases Institute Kampala, Uganda

International Ctr for Excellence in Research and Rakai Health Sciences Program Rakai, Uganda

View Trial Details

Completed

Evaluate the Efficacy and Security of Darunavir/Ritonavir 900/100 mg Once a Day as an Antiretroviral Treatment Simplification Strategy

NCT00611039

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: Germans Trias i Pujol Hospital Badalona, Barcelona, Spain

View Trial Details

Completed

Pilot Study to Compare the Pharmacokinetics Parameters in Plasma and Intracellular of Raltegravir Administered Once a Day in Adult Patients Infected With HIV

NCT00995241

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: Hospital Germans Trias i Pujol Badalona, Barcelona, Spain

Hospital de la Santa Creu i Sant Pau Barcelona, Spain

View Trial Details

Completed

Clinical Trial Assessing Once Daily Raltegravir Administration (800 mg QD) in HIV-1-Infected Patients Receiving Unboosted Atazanavir (400 mg QD)- Based Antiretroviral Therapy

NCT00718536

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: Germans Trias i Pujol Hospital Badalona, Barcelona, Spain

View Trial Details

Completed

Screening Protocol for HIV Vaccine Studies

NCT00031304

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Socioenvironmental Determinants of Psychological Functioning, Mental Health and AIDS in Mali

NCT00339391

Conditions: AIDS, Acquired Immunodeficiency Syndrome, Behavior, +19 more
Locations: Centre Regional de Medecine Traditionnelle Bamako, Mali

View Trial Details

Completed

Peginterferon Alfa-2a, Ribavirin and Epoetin β in Coinfected Patients HCV/HIV Not Responding to Previous Treatment Regimens

NCT00470210

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +17 more
Locations: Hospital Germans Trias i Pujol Badalona, Barcelona, Spain

Hospital del Mar Barcelona, Spain

View Trial Details

Lentivirus Infections

Lentivirus Infections trial results

Related conditions